APC testifies on Delaware proposal
Published November 18, 2022
APC Board Chair-Elect Anthony Grzib spoke on behalf of APC during the open comment period of the Delaware Board of Pharmacy meeting on Wednesday November 16.
APC News
PCF announces 2023 leadership
Published November 18, 2022
Please join us in welcoming the Pharmacy Compounding Foundation's 2023 Board of Directors.
APC signs letter supporting antitrust bill
Published November 18, 2022
Earlier this week, APC and two dozen other independent business organizations signed a letter to Congressional leaders, urging them to prioritize an antitrust bill that targets tech giants during the lame-duck session.
December 8 webinar: How to leverage medical literature to support your compounded therapies
Published November 17, 2022
Speaker Nat Jones, RPh, FAPC, will show attendees how to identify and use medical research to help you better help your patients.
FOR TECHNICIANS ONLY: Here’s a career-changing opportunity for you
Published November 16, 2022
You can join the ranks of the elite technicians...and we can show you how.
Bormel says “DTE remains available.” But how?
Published November 11, 2022
This week's DTE discussion with FDA made some progress, but there's more work to be done by compounders.
Registration opens for “Best Practices” Conference
Published November 11, 2022
Register by January 4, 2023 for early bird pricing.
Hey PFMs: Stick it!
Published November 7, 2022
We recently sent our Pharmacy/Facility Members a magnet with a message to "stick it!"
Chapter <797> includes BUD, batch size restrictions
Published November 4, 2022
The revised USP Chapter <797> related to sterile compounding, released on Tuesday, includes restrictions on beyond-use dates and batch size for CSPs that APC and others had argued were not supported by scientific evidence.
A confusing proposed rule in Delaware
Published November 4, 2022
A proposed rule by the Delaware Board of Pharmacy has the potential to limit office stock compounding for veterinarians by 503A pharmacies. APC is submitting a comment letter and will be attending the board meeting on November 16.
Share this: The PCF scholarship application is now open
Published November 2, 2022
The Pharmacy Compounding Foundation (PCF) will award up to two $2,500 scholarships in 2023 to pharmacy students who have demonstrated commitment to a career in compounding pharmacy in the US.
It takes a lot of money to make nothing happen.
Published October 28, 2022
It has been two years since we started talking about FDA’s implicit threat to restrict compounded hormones. So far, the agency has done nothing.
Burch, Brunner recently featured on menopause-focused podcast
Published October 28, 2022
APC member Jennifer Burch (owner of Central Compounding Center, Durham, NC) and APC CEO Scott Brunner recently did their part to clear the confusion regarding compounded hormone therapy and enhance awareness of its many benefits.
Win BIG at APC’s Quiz Show on Nov 10*
Published October 28, 2022
*By "win BIG" we mean that the knowledge you gain will help you be the best gosh darn compounding pharmacist you can be.
Coming soon: EduCon 2023
Published October 28, 2022
Assure your team has the current expertise it needs to practice with high competence and integrity by joining us for EduCon 2023 Virtual: Best Practices in Compounding.
It takes a lot of money to make nothing happen.
Published October 26, 2022
It’s been two years since we started talking about FDA’s implicit threat to restrict compounded hormones. So far, the agency has done nothing. But "nothing" is a good thing.
FDA agrees to meeting on DTE
Published October 21, 2022
FDA representatives have agreed to meet on Nov 9 with APC and other pharmacy organization leaders about FDA’s recent apparent reclassification of desiccated thyroid extract (DTE) as a biologic.
We asked, FDA listened
Published October 21, 2022
On December 14, FDA is hosting a webinar, "What to Expect after an Inspection: 483s, Responses and Beyond."
FDA extends period before enforcing out-of-state distribution limits
Published October 21, 2022
The pre-enforcement period was originally scheduled to end on October 27, 2022.
Patients respond to cBHT “Special Report”
Published October 21, 2022
A recent email campaign has resulted in 19 additional contributions—totaling more than $16,000—to APC’s Save Compounded Hormones Campaign. It has also resulted in more than 70 new patient testimonials this week at compounding.com
What compounding software are you using?
Published October 21, 2022
Will you please tell us which compounding software you’re using? This short survey will only take a few minutes.
Welcome to our newest PFMs
Published October 21, 2022
APC offers a pharmacy/facility membership (PFM) as an alternative to purchasing several individual memberships.
USP to release new <795> and <797>
Published October 14, 2022
Did they or didn’t they? Did USP take seriously input from APC (as well as that of APhA, NCPA, and numerous other pharmacy stakeholder groups)?
Short Video: He’s using OutcomeMD … and thriving!
Published October 14, 2022
Jack Korbutov says the system is already paying dividends.
Legal settlement spurs FDA to develop 503B bulks list
Published October 14, 2022
The Outsourcing Facilities Association announced this week that it reached a settlement agreement with the FDA.
MOCs to FDA: “We are troubled”
Published October 7, 2022
Eight members of Congress wrote to FDA Center for Veterinary Medicine director Dr. Steven Solomon this week to express concern that CVM’s GFI 256 on animal compounding may result in delayed care for veterinary patients.
New Model Act incorporates APC-recommended compounding questionnaire
Published October 7, 2022
Several changes to NABP’s new Model Act were recommended by APC, including a requirement that licensed compounding pharmacies provide to the state board of pharmacy basic information about their compounding operations.
100 MOCs sign letter to TRICARE
Published October 7, 2022
One hundred members of Congress signed a letter of concern sent last week to the Department of Defense in response to recent TRICARE changes that threaten beneficiaries’ access to community pharmacies, especially in rural areas.
Two proposed state regs changes to be aware of
Published October 6, 2022
Kentucky and Arkansas have recently proposed regulations changes to be aware of.
The threat to compounded hormones just got real
Published September 30, 2022
See inside for details, then take our survey and attend our stakeholder briefing on October 13.
